Heinz von der Höh N, Pieroh P, Henkelmann J, et al. - This inquiry was performed among patients with pyogenic spondylodiscitis transmitted due to infected retroperitoneal regions of primary infected mycotic aortic aneurysms (MAAs) or secondary infected aortic stent grafts following endovascular aneurysm repair (EVAR), to describe the challenging therapeutic approach as well as the clinical outcome. From 2012 to 2019, researchers identified 15 patients with spondylodiscitis transmitted from primary or secondary infected aortic aneurysms after EVAR for inclusion. This is the largest case series of cases with spondylodiscitis linked with infected aortic stent grafts. In this highly specific patient population, close interdisciplinary cooperation pre-, inter- and postoperatively is essential and necessitates the consideration of individual therapy. Researchers observed short-term recovery with no serious complications in correlation with using posterior approach with debridement and stabilization of spondylodiscitis. Thus, they suggest this management strategy to be a therapeutic strategy for these patients.